SW Metformin 850mg Tablet

Država: Malezija

Jezik: engleski

Izvor: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Kupi sada

Uputa o lijeku Uputa o lijeku (PIL)
01-07-2020
Svojstava lijeka Svojstava lijeka (SPC)
05-11-2020

Aktivni sastojci:

METFORMIN HYDROCHLORIDE

Dostupno od:

SUNWARD PHARMACEUTICAL SDN. BHD.

INN (International ime):

METFORMIN HYDROCHLORIDE

Jedinice u paketu:

100Tablet Tablets; 500 Tablet Tablets; 1000 Tablet Tablets; 500 Tablet Tablets; 100 Tablet Tablets

Proizveden od:

SUNWARD PHARMACEUTICAL SDN. BHD.

Uputa o lijeku

                                METFORMIN TABLET
Metformin Hydrochloride (250/500/850mg) 1
_ CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_
WHAT IS IN THIS LEAFLET
1. What SW Metformin Tablet is used for
2. How SW Metformin Tablet works
3. Before you use SW Metformin Tablet
4. How to use SW Metformin Tablet
5. While you are using it
6. Side effects
7. Storage and Disposal of SW Metformin
Tablet
8. Product Description
9. Manufacturer and Product Registration
Holder
10. Date of revision
WHAT SW METFORMIN TABLET IS USED FOR
It is used as treatment to control high blood
sugar which is not responsive to diet alone or
diet plus treatment with sulphonylurea.
HOW SW METFORMIN TABLET WORKS
The
active
ingredient
in
the
medicine
is
metformin
hydrochloride.
Metformin
HCL
works in lowering the production of glucose
in
liver
by
three
way
mechanisms
which
known
in
reduction
of
hepatic
glucose
production, increasing insulin sensitivity in
muscle and uptake in peripheral tissue and
also delay of intestinal glucose absorption.
Metformin
has
favourable
effects
on
lipid
metabolism. This shown at therapeutic doses
in controlled of medium or long term clinical
studies that metformin reduce the level of
total
cholesterol,
LDL
cholesterol
and
triglycerides.
BEFORE YOU USE SW METFORMIN TABLET
_- When you must not use it _
Do not take SW Metformin Tablet if you:-

have liver problem.

have severely reduced kidney function.

have lactic acidosis [too much lactic acid in
the
blood
(see
“Risk
of
lactic
acidosis”
below)] or ketoacidosis. Ketoacidosis is a
condition
in
which
substances
called
‘ketone bodies’ accumulate in the blood
and which can lead to diabetic pre-coma.
Symptoms
of
acidosis
may
include
stomach
pain,
abnormal
breathing
and
drowsiness (if severe).

have
heart
problem
or
congestive
heart
failure.

have low blood pressure.

have diabetes mellitus with excesive acid
level in body.

have
infectious
disease
or
tissue
death
problem.

are during surgery.

are hypersensitivity to metformin HCL or
any
ingredients
listed
at
the
end
                                
                                Pročitajte cijeli dokument
                                
                            

Svojstava lijeka

                                METFORMIN 250 / 850 TABLET
Each tablet contains:-
Metformin HCl
250mg / 850mg
PHARMACOLOGY:
Metformin is a biguanide with antihyperglycaemic effects, lowering
both basal and postprandial plasma glucose. It does not stimulate
insulin secretion and therefore does not produce hypoglycaemia.
Metformin may act via 3 mechanisms: Reduction of hepatic glucose
production by inhibiting gluconeogenesis and glycogenolysis; in muscle
by increasing insulin sensitivity, improving peripheral glucose
uptake and utilisation; and delay of intestinal glucose absorption.
Metformin stimulates intracellular glycogen synthesis by acting on
glycogen synthase. Metformin increases the transport capacity of all
types of membrane glucose transporters (GLUT). In humans,
independently of its action on glycaemia, metformin has favourable
effects on lipid metabolism. This has been shown at therapeutic doses
in controlled, medium-term or long-term clinical studies; metformin
reduces total cholesterol, LDL cholesterol and triglyceride levels.
PHARMACOKINETICS:
After an oral dose of metformin, Tmax is reached in 2.5 hours.
Absolute bioavailability of a 500mg or 850mg metformin tablet is
approximately 50-60% in healthy subjects. Metformin is excreted
unchanged in the urine. No metabolites have been identified in
humans.
INDICATIONS:
It is used in the treatment of maturity on-set diabetes melitus not
responsive to diet alone or diet plus treament with a sulphonylurea.
SIDE EFFECTS/ ADVERSE REACTIONS:
Anorexia, nausea, vomiting and diarrhoea are not uncommon;
occasionally a metallic taste, loss of weight, weakness, lassitude or
skin
rashes may occur.
Lactic acidosis possibly heralded by vomiting, abdominal pain,
hyperventilation and diminished consciousness may accur.
CONTRAINDICATIONS:
Metformin hydrochloride should not be given to patients with impaired
hepatic or renal unction, cardiovascular collpase, congestive heart
failure, acute myocardial infarction or other conditions leading to
hypotension or to hypoxaemia. It should not be given to pati
                                
                                Pročitajte cijeli dokument
                                
                            

Dokumenti na drugim jezicima

Uputa o lijeku Uputa o lijeku malajski 01-07-2020

Upozorenja za pretraživanje vezana za ovaj proizvod